Navignostics

About:

Navignostics aims to identify the ideal treatment to each cancer patient’s disease.

Website: https://www.navignostics.com/

Top Investors: Bruker, Zürcher Kantonal Bank, Think.Health, UZH Life Sciences Fund, Ventura BioMed Investors

Description:

Our mission is to identify the ideal treatment to battle each cancer patient’s disease and reduce suffering throughout their journey. At Navignostics we characterize tumors using spatial single-cell proteomics. We use our unique capabilities to identify a cancer treatment that will optimally fight each patient’s tumor. We also accelerate cancer drug development by providing key insights into drug mechanisms and tumor features for companion diagnostic development. Our highly robust and reliable technology and our leading data analytics position us ideally to enable precision cancer diagnostics for patients and to provide services to pharma and biotech partners. This way we help people suffering from cancer by making more drugs available and by finding the right one for every patient.